Hepatitis B Reactivation in Patients Positive for Hepatitis B Surface Antigen Undergoing Autologous Hematopoietic Cell Transplantation

References

• Lau, G.K.K., Leung, Y.H., Daniel, Y.T. E, Wing-yan, A., Yok-lam, K., Albert, L., Ji-lin, H., Yu-mei, W., Amin, N. and Raymond, L. (2002) "High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous haematopoietic cell transplantation", Blood 99, 2324–2330.
   Google Scholar
• Liang, R., Lau, G.K.K. and Kwong, Y.L. (1999) "Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem", J. Clin. Oncol. 17, 394–398.
   PubMed Web of Science ®Google Scholar
• Webster, A., Brenner, M.K., Prentice, H.G. and Griffiths, RD. (1989) "Fatal hepatitis B reactivation after autologous bone marrow transplantation", Bone Marrow Transplant. 4(2), 207–208.
   PubMed Web of Science ®Google Scholar
• Ustun, C., Koc, H., Karayalcin, S., et al. (1997) "Hepatitis B virus infection in allogeneic bone marrow transplantation", Bone Marrow Transplant. 20, 289–296.
   PubMed Web of Science ®Google Scholar
• Pariente, E.A., Goudeau, A., Dubois, F., et al. (1988) "Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation", Dig. Dis. Sci. 33, 1185–1191.
   PubMed Web of Science ®Google Scholar
• Dhedin, N., Douvin, C., Kuentz, M., et al. (1998) "Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc", Transplantation 66, 616–619.
   PubMed Web of Science ®Google Scholar
• Martin, BA., Rowe, J.M., Kouides, P.A. and DiPersio, J.F. (1995) "Hepatitis B reactivation following allogeneic bone marrow transplantation: a case report and review of the literature", Bone Marrow Transplant. 15, 145–148.
   PubMed Web of Science ®Google Scholar
• Chen, P.M., Liu, J.H., Fan, ES., et al. (1995) "Liver disease after bone marrow transplantation: the Taiwan experience", Transplan-tation 59, 1139–1143.
   PubMed Web of Science ®Google Scholar
• Iwai, K., Tashima, M., Itoh, M., et al. (2000) "Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period", Bone Marrow Transplant. 25, 105–108.
   PubMed Web of Science ®Google Scholar
• Kostaridou, S., Ladis, V, Kattamis, A., Laras, A. and Hadziyannis, S.J. (1998) "HBeAg-negative hepatitis B in a previously thalassemic patient during immunosuppressive therapy for chronic GVHD", Bone Marrow Transplant. 22, 919–921.
   PubMed Web of Science ®Google Scholar
• Caselitz, M., Link, H., Hein, R., et al. (1997) "Hepatitis B associated liver failure following bone marrow transplantation", J. Hepatol. 27, 572–577.
   PubMed Web of Science ®Google Scholar
• Lau, G.K., Liang, R., Chiu, E.K., Lee, C.K. and Lam, S.K. (1995) "Loss of HBsAg in chronic hepatitis B carrier following high dose chemotherapy and autologous peripheral blood stem cell rescue for lymphoma", Am. J. Haematol. 50(4), 317–318.
   Web of Science ®Google Scholar
• Mason, A.L., Wick, M., White, H.M., Benner, K.G., Lee, R.G., Regenstein, F., Riely, CA., Bain, V.G., Campbell, C. and Perrillo, RP. (1993) "Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatits", Gastroenterology 105(1), 237–244.
   PubMed Web of Science ®Google Scholar
• Hoofnagle, J.H., Dusheiko, G.M., Schafer, D.F., et al. (1982) "Reactivation of chronic hepatitis B virus infection by cancer chemotherapy", Ann. Intern. Med. 96, 447–449.
   PubMed Web of Science ®Google Scholar
• Davis, G.L. and Hoofnagle, J.H. (1987) "Reactivation of chronic hepatitis B virus infection", Gastroenterology 92, 2028–2031.
   PubMed Web of Science ®Google Scholar
• McMillan, J.S., Shaw, T., Angus, P.W. and Locarnini, S.A. (1995) "Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro", Hepatology 22, 3643.
   Web of Science ®Google Scholar
• Wands, J.R., Chura, CM., Roll, F.J. and Maddrey, W.C. (1975) "Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders", Gastroenterology 68, 105–112.
   PubMed Web of Science ®Google Scholar
• Nagington, J., Cossart, YE. and Cohen, B.J. (1977) "Reactivation of hepatitis B after transplantation operations", Lancet 68, 105–112.
   Google Scholar
• Scullard, G.H., Smith, CI., Merigan, T.C., Robinson, W.S. and Gregory, P.B. (1981) "Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B", Gastroenterology 81, 987–991.
   PubMed Web of Science ®Google Scholar
• Galbraith, R.M., Eddleston, A.L.W.F., Williams, R., Zuckerman, A.J. and Bagshawe, K.D. (1975) "Fulminant hepatic failure in leukemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy", Lancet 2, 528–530.
   PubMed Web of Science ®Google Scholar
• Jones, R.J., Lee, K.S. and Saral, R. (1987) "Venoocclusive disease of the liver following bone marrow transplantation", Transplan-tation 44(6), 778–783.
   PubMed Web of Science ®Google Scholar
• Glucksberg, H., Storb, R., Fefer, A., Buckner, CD., Neiman, P.E., Clift, R.A., Lerner, KG. and Thomas, ED. (1974) "Clinical manifestations of graft-versus-host disease in human recipients of marrow from FILA-matched sibling donors", Transplantation 18(4), 295–304.
   Google Scholar
• Steinberg, J.L., Yeo, W., Thong, S., et al. (2000) "Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role", J. Med. Virol. 60, 249–255.
   PubMed Web of Science ®Google Scholar
• Cooksley, W.G. and Mclvor, C.A. (1995) "Fibrosing cholestatic hepatitis and HBV after bone marrow transplantation", Biomed. Phannacother 49(3), 117–124.
   PubMed Web of Science ®Google Scholar
• Duclos-Vallee, J.C., Laurent-Puig, P., Loriot, MA., Buffet, C. and Etienne, J.P. (1994) "Fatal reactivation of hepatitis B virus mutant following cytotoxic treatment", J. Hepatol. 21(6), 1152.
   PubMed Web of Science ®Google Scholar
• McIvor, C., Morton, J., Bryant, A., Cooksley, W.G., Durrant, S. and Walker, N. (1994) "Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation", Ann. Intern. Med. 121, 274–275.
   PubMed Web of Science ®Google Scholar
• Yoshiba, M., Sekiyama, K., Sugata, F., et al. (1992) "Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment", Dig. Dis. Sci. 37, 1253–1259.
   PubMed Web of Science ®Google Scholar
• Talbodec, N., Loriot, M.A., Gigou, M., Guigonis, V, Boyer, N., Bezeaud, A., Effinger, S., Benhamou, J.P. and Marcellin, P. (1995) "Hepatitis B virus precore mutations and HbeAg negative reactivation of chronic hepatitis B after interferon therapy", Liver 15(2), 93–98.
   PubMedGoogle Scholar
• Kryger, P. (1985) "Significance of anti-fffic IgM in the differential diagnosis of viral hepatitis", J. Virol. Methods 10(4), 283–289.
   PubMed Web of Science ®Google Scholar
• Chau, K.H., Hargie, M.P., Decker, R.H., Mushahwar, LK. and Overby, L.R. (1983) "Serodiagnosis of recent hepatitis B infection by IgM class anti-HBc", Hepatology 3(2), 142–149.
   PubMed Web of Science ®Google Scholar
• Colloredo Mels, G., Bellati, G., Leandro, G., Brunetto, M.R., Vicari, 0., Piantino, P., Borzio, M., Angell, G., Ideo, G. and Bonino, F. (1993) "Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations", Arch. Virol. Suppl. 8, 203–211.
   Google Scholar
• Carman, WE, Korula, J., Wallace, L., MacPhee, R., Mimms, L. and Decker, R. (1995) "Fuhninant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal 1-113sAg ELISA", Lancet 3345(8962), 1406–1407.
   Web of Science ®Google Scholar
• Lau, J.Y., Bird, G.L., Gimson, A.E., et al. (1991) "Treatment of HBV reactivation after withdrawal of immunosuppression", Lancet 337, 802.
   PubMed Web of Science ®Google Scholar
• Lok, A.S., Liang, R.H., Chiu, E.K., Wong, K.L., Chan, T.K. and Todd, D. (1991) "Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study", Gastroenterology 100, 182–188.
   PubMed Web of Science ®Google Scholar
• Lai, C.L., Chien, RN., Leung, NW., et al. (1998) "A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group", N. Engl. J. Med. 339, 61–68.
   PubMed Web of Science ®Google Scholar
• Dienstag, J.L., Schiff, ER., Wright, T.L., et al. (1999) "Lamivudine as initial treatment for chronic hepatitis B in the United States", N. Engl. J. Med. 341, 1256–1263.
   PubMed Web of Science ®Google Scholar
• Main, J., Brown, J.L., Howells, C., Galassini, R., Crossey, M., Karayiannis, P., Georfiou, P., Atkinson, G. and Thomas, H.C. (1996) "A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection", J. Viral Hepat. 3(4), 211–215.
   PubMed Web of Science ®Google Scholar
• Trepo, C., Jezek, P., Atkinson, G., et al. (2000) "Famciclovir in chronic hepatitis B: results of a dose-finding study", J. Hepatol. 32, 1011–1018.
   PubMed Web of Science ®Google Scholar
• de Man, R.A., Marcellin, P., Habal, F., et al. (2000) "A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B", Hepatology 32, 413–417.
   PubMed Web of Science ®Google Scholar
• Lau, G.K.K., Lie, A.K.W., Kwong, Y.L., et al. (2000) "A case-controlled study on the use of FffisAg positive donors for allogeneic hematopoietic cell transplantation", Blood 96, 452–458.
   PubMed Web of Science ®Google Scholar
• Lau, G.K.K., Tsiang, M., Hou, J., et al. (2000) "Combination therapy with lamivudine and famciclovir for Chronic hepatitis B infected Chinese: a viral dynamics study", Hepatology 32, 394–399.
   PubMed Web of Science ®Google Scholar
• Yeo, W., Steinberg, J.L., Tam, LS., et al. (1999) "Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy", J. Med. Virol. 59, 263–269.
   PubMed Web of Science ®Google Scholar
• Maguire, C.M., Crawford, D.H., Hourigan, L.F., et al. (1999) "Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy", J. Gastroenterol. Hepatol. 14, 801–803.
   PubMed Web of Science ®Google Scholar
• Clark, F.L., Drummond, M.W., Chambers, S., et al. (1998) "Successful treatment with lamivudine for fuhninant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma", Ann. Oncol. 9, 385–387.
   PubMed Web of Science ®Google Scholar
• Ahmed, A. and Keeffe, E.B. (1999) "Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection", Am. J. Gastroenterol. 94, 249–251.
   PubMed Web of Science ®Google Scholar
• Tang, S.N., Ho, S.K., Moniri, K., Neng Lai, K. and Mao Chan, T. (2002) "Efficacy of famciclovir in the treatment of Lamivudine resistance related to an atypical hepatitis B virus mutant", Transplantation 15, 148–151.
   Web of Science ®Google Scholar
• Lau, G.K.K., He, AIL., Fong, D.Y., Bartholomeusz, A., Au, WY., Lie, A.K., Locarnini, S. and Liang, R. (2002) "Preemptive use of lamivuidine reduces hepatitis B exacerbation after allogeneic haematopoietic cell transplantation", Hepatology 36(3), 702–709.
   PubMed Web of Science ®Google Scholar
• Chan, T.M., Fang, G.X., Tang, CS., Cheng, I.K., Lai, K.N. and Ho, S.K. (2002) "Preemptive lamuvidine therapy based on HBV DNA level in fffisAg-positive kidney allograft recipients", Hepatology 36(5), 1246–1252.
   PubMed Web of Science ®Google Scholar
• Leung, N. (2000) "Nucleoside analogues in the treatment of chronic hepatitis B", J. Gastroenterol. Hepatol. 15, E53—E60.
   PubMed Web of Science ®Google Scholar
• Hussain, M. and Lok, A.S. (1999) "Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis B", J. Viral Hepat. 6, 183–194.
   PubMed Web of Science ®Google Scholar
• Buckwold, YE., Xu, Z., Chen, M., Yen, T.S. and Ou, J.H. (1996) "Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication", J. Virol. 70, 5845–5851.
   PubMed Web of Science ®Google Scholar
• Onto, E., Mizokami, M., Sakugawa, H., et al. (2001) "A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group", Hepatology 33, 218–223.
   PubMed Web of Science ®Google Scholar
• Kao, J.H., Chen, P.J., Lai, M.Y. and Chen, D.S. (2000) "Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B", Gastroenterology 118, 554–559.
   PubMed Web of Science ®Google Scholar
• Shaw, T. and Locarnini, S. (2000) "Combination chemotherapy for hepatitis B virus: the final solution?", Hepatology 32, 430–432.
   PubMed Web of Science ®Google Scholar
• Marcellin, P. (2002) "Advances in therapy for chronic hepatitis B", Semin. Liver Dis. 22\(Suppl. 1), 33–36.
   PubMed Web of Science ®Google Scholar
• Liaw, Y.F. (2002) "Therapy of chronic hepatitis B: current challenges and opportunities", J. Viral Hepat. 9(6), 393–399.
   PubMed Web of Science ®Google Scholar
• Delaney, IV, W.E., Edwards, R., Colledge, D., Shaw, T., Furman, P., Painter, G. and Locarnini, S. (2002) "Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro", Antimicrob. Agents Chemother 46(9), 3057–3060.
   PubMed Web of Science ®Google Scholar